跳至主要内容
临床试验/CTRI/2024/05/068084
CTRI/2024/05/068084尚未招募1 期

To assess the utility of individualized homoeopathic medicine in management of cystitis. A single arm open label interventional study. - nil

Dr. Bilal Khan0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of all age group.
  • 2. Patients of all sexes.
  • 3. Diagnostic criteria are mainly on clinical presentation and urine culture will be done when required.
  • 4. Patient willing to participate in study and provide written consent.

排除标准

  • 1. Patients not willing to participate in the study.
  • 2. Any medical condition or disease which might interfere with the assessments (e.g.MR, Hearing impairment or speech problems).
  • 3. Patients suffering from Malignancy, Tuberculosis and Systemic disorders such as Diabetes Mellitus, Thyroid dysfunction etc.
  • 4. Patients who require emergency medical treatment.
  • 5. Cases of interstitial cystitis, hemorrhagic cystitis, malakoplakia, cystitis cystica.
  • 6. Pregnant and lactating women.
  • 7. Patient participating in any other clinical study.
  • 8. Cases that do not fulfill the inclusion criteria.

研究者

发起方
Dr. Bilal Khan

相似试验